SCHEMBL4682014

SCHEMBL4682014

CCN(CC1CCNCC1)[C@@H](C)Cc1ccc(OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SLC6A4 P31645 3/20 0.40
▸ CYP2D6 P10635 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ SLC6A2 P23975 2/20 0.40
▸ ADRB2 P07550 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4679718 1.00 TDP1 (0.47) TDP1ALDH1A1SMN1; SMN2SLC6A4CYP2D6
Hydrochloric Acid SCHEMBL4685022 0.99 TDP1 (0.49) TDP1ALDH1A1SMN1; SMN2SLC6A4CYP2D6
Hydrochloric Acid SCHEMBL4684309 0.98 TDP1 (0.48) TDP1ALDH1A1SMN1; SMN2SLC6A4CYP2D6
Hydrochloric Acid SCHEMBL4684310 0.98 TDP1 (0.48) TDP1ALDH1A1SMN1; SMN2SLC6A4CYP2D6
Hydrochloric Acid SCHEMBL4682672 0.78 CYP2D6 (0.61) ALDH1A1SMN1; SMN2SLC6A4CYP2D6CYP3A4
Hydrochloric Acid SCHEMBL4682431 0.78 CYP2D6 (0.61) ALDH1A1SMN1; SMN2SLC6A4CYP2D6CYP3A4
SCHEMBL4680567 0.78 CYP2D6 (0.45) ALDH1A1SMN1; SMN2SLC6A4CYP2D6CYP3A4
SCHEMBL4678547 0.78 CYP2D6 (0.43) ALDH1A1SMN1; SMN2SLC6A4CYP2D6CYP3A4
Hydrochloric Acid SCHEMBL4682430 0.78 CYP2D6 (0.61) ALDH1A1SMN1; SMN2SLC6A4CYP2D6CYP3A4
Hydrochloric Acid SCHEMBL4683782 0.78 CYP3A4 (0.43) ALDH1A1SMN1; SMN2SLC6A4CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 — — EP disclosed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 — — US disclosed
EP-1058680-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 — — EP disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 — — WO disclosed
Send feedback